Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

VTGNVTGN
Showing 8 of 11 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in VISTAGEN THERAPEUTICS INC

Yes. Two Sigma holds 847,992 shares of VTGN (Vistagen Therapeutics), worth $191,646, as of its Q2 2026 13F filing. It increased the position by 378,373 shares (+80.6%) from Q1 2026. Two Sigma has held VTGN since Q4 2023, across 11 quarterly 13F filings.

Current Value

$191,646

Current Shares

847,992

Total Value Change

+$6,405

Total Shares Change

+786,450

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
847,992
+80.6%
$191,6460.0%$0.23
35
2026-Q1
Increased
469,619
+140.1%
$268,3870.0%$0.57
38
2025-Q4
Decreased
195,570
-32.4%
$129,4480.0%$0.66
0
2025-Q3
Increased
289,409
+223.5%
$1M0.0%$3.55
40
2025-Q2
Decreased
89,451
-20.5%
$178,9020.0%$2.00
0
2025-Q1
Decreased
112,507
-18.1%
$281,2680.0%$2.50
0
2024-Q4
Increased
137,334
+123.2%
$405,1350.0%$2.95
38
2024-Q3
Decreased
61,542
-8.8%
$185,2410.0%$3.01
0

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used